Sabine D. Brookman-May/X
Sep 7, 2024, 09:51
Excellent exchange and discussion on urothelial carcinoma clinical trials
Sabine D. Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, shared a post by UroToday.com, on X:
“Excellent exchange and discussion
need for control arms in clinical trials reflecting SOC NMIBC need for accurate risk categorization of patients role of Biomarkers – ctDNA.
Quoting UroToday.com’s post:
“Guidelines aim to harmonize and optimize urothelial carcinoma clinical trials.
Ashish M. Kamat and Mathew Galsky join Sam S. Chang to discuss new trial parameters and the urgent need for detailed guidelines due to the dynamic landscape of treatment .
Authors: Ashish M. Kamat, Mathew Galsky, Sam S. Chang”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 04:55
Mar 29, 2025, 04:16
Mar 28, 2025, 20:11
Mar 28, 2025, 19:58
Mar 28, 2025, 19:38